Legal Opinion
Galderma Labs., L.P. v. Amneal Pharm., LLC
District Court, D. Delaware
Decided August 27, 2018No. C.A. No. 16-207-LPSPublishedCited by 2 opinions
1Opinion of the Court
STARK, U.S. District Judge:
OPINION
In March 2016, Plaintiffs Galderma Laboratories, L.P. ("Galderma"), Nestlé Skin Health S.A. ("NSH"), and TCD Royalty Sub, LLC ("TCD" and, with Galderma and NSH, "Galderma" or "Plaintiffs") filed suit against Defendants Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals Co. (I) Pvt. Ltd. (collectively, "Amneal" or "Defendants") under the Hatch-Waxman Act, 35 U.S.C. § 271(e). (See D.I. 1) Defendants seek to bring to market a generic version of Plaintiffs' Oracea ® Capsules, a once-daily 40 milligram ("mg") administration of doxycycline for the treatment of…
2Cases cited67 opinions
- Parklane Hosiery Co. v. ShoreSupreme Court of the United States · 1979
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Herbert Markman and Positek, Inc. v. Westview Instruments, Inc. And Althon Enterprises, Inc.Court of Appeals for the Federal Circuit · 1995
- Taylor v. SturgellSupreme Court of the United States · 2008
- Graver Tank & Mfg. Co. v. Linde Air Products Co.Supreme Court of the United States · 1950
62 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Galderma Laboratories, L.P. v. Sun Pharmaceutical Industries LimitedDistrict Court, D. Delaware · 2019
- Scale Biosciences, Inc. v. Parse Biosciences, Inc.District Court, D. Delaware · 2025